PDCD1 and neoplasm: The cell surface expressed programmed cell death 1 (PD-1) receptor has been implicated in tumor immune evasion of many cancer types through mediating inhibitory signals upon engagement of its ligand, PD-L1, expressed on tumors [14–17].